Purple Biotech
(NASDAQ) PPBT
Purple Biotech Financials at a Glance
Market Cap
$3.68M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.73M
EPS (TTM)
$-34.11
P/E Ratio
-0.12
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$4.10
Volume
13,523
Open
$4.10
Price
$4.10
Volume
13,523
Open
$4.10
Previous Close
$4.14
Daily Range
$3.79 - $4.18
52-Week Range
$3.65 - $29.40
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$4.10
Volume
13,523
Open
$4.10
Previous Close
$4.14
Daily Range
$3.79 - $4.18
52-Week Range
$3.65 - $29.40
PPBT News
PPBT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Purple Biotech
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Gil Efron, MBA, CPA
Website
www.purple-biotech.comHeadquarters
Rehovot, 7670104, IL
PPBT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-125%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-8.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.68M
Shares Outstanding
929.20K
Volume
13.52K
Short Interest
0.00%
Avg. Volume
12.98K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$27.68M
EBITDA
$27.68M
Operating Cash Flow
$5.54M
Capital Expenditure
$3.02K
Free Cash Flow
$5.54M
Cash & ST Invst.
$9.57M
Total Debt
$244.00K
Purple Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$3.68M
N/A
Market Cap/Employee
$409.38K
N/A
Employees
9
N/A
Net Income
$23.89M
-5726.2%
EBITDA
$23.59M
-2562.8%
Quarterly Fundamentals
Net Cash
$9.33M
+11.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$244.00K
-33.3%
Return on Assets
-1.64%
N/A
Return on Invested Capital
-3.03%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$1.04M
+48.3%